{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:45:49Z","timestamp":1782215149527,"version":"3.54.5"},"reference-count":32,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can Assoc Radiol J"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    <jats:bold>Purpose:<\/jats:bold>\n                    To evaluate frequency and distribution of immune-related adverse events detected by\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT in patients with metastatic melanoma undergoing immunotherapy.\n                    <jats:bold>Materials and Methods:<\/jats:bold>\n                    Retrospective observational cohort study evaluating 147 patients with metastatic melanoma treated with immunotherapy and referred for therapy response assessment with\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT at our institution from January 2010 to August 2022. In total, 201 PET\/CT scans performed at various time points were analyzed. IRAEs detected on PET\/CT were compared against clinical reference standards, including physical examinations, laboratory tests, and biopsies. Diagnostic performance metrics (sensitivity, specificity, positive predictive value, negative predictive value), and diagnostic yields were calculated.\n                    <jats:bold>Results:<\/jats:bold>\n                    There were 36\/147 patients (24.5%) with IRAEs recorded according to standard of reference, with 39 IRAEs in the entire cohort. At time point level, PET\/CT identified 36\/36 (100%) patients with IRAEs confirmed by the reference standard, while clinical suspicion identified 26\/36 (72%) cases. At IRAE level, PET\/CT identified 36\/39 (92%) of IRAEs confirmed by the reference standard. Thirteen out of 39 (33.3%) cases identified on PET\/CT were not suspected clinically but confirmed by the reference standard. The most frequent IRAEs, both suspected clinically and on PET\/CT, corresponded to thyroiditis and colitis. Among the PET\/CT positive cases, the majority corresponded to grade 2 severity.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT is highly effective in detecting IRAEs in patients with metastatic melanoma on immunotherapy, uncovering clinically unsuspected events in up to 33% of cases. These results highlight its important role in early detection, guiding timely interventions, and improving overall outcomes of immunotherapy-related toxicities.\n                  <\/jats:p>","DOI":"10.1177\/08465371251334929","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:45:37Z","timestamp":1746067537000},"page":"720-730","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["<sup>18<\/sup>\n                    F-FDG PET\/CT for the Detection of Immune-Related Adverse Events in Patients With Metastatic Melanoma Receiving Immunotherapy"],"prefix":"10.1177","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-3451","authenticated-orcid":false,"given":"Vanessa","family":"Murad","sequence":"first","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-8994","authenticated-orcid":false,"given":"Ur","family":"Metser","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Kohan","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Murad","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Veit-Haibach","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ortega","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women\u2019s College Hospital, Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018181349"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31349"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9235638"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-017-0256-2"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0029"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00730"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30050355"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2021200093"},{"key":"e_1_3_3_11_2","article-title":"The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors","volume":"65","author":"Demlova R","year":"2016","unstructured":"Demlova R, Valik D, Obermannova R, ZdraZilova-Dubska L. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors. Physiol Res. 2016;65(Suppl 4):S455-S462.","journal-title":"Physiol Res"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00049"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.001"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2017.12.014"},{"key":"e_1_3_3_15_2","first-page":"2140","article-title":"Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade","volume":"18","author":"Sakakida T","year":"2019","unstructured":"Sakakida T, Ishikawa T, Uchino J, et al. Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade. Oncol Lett. 2019;18:2140-2147.","journal-title":"Oncol Lett"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2017.18.1.42"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0102"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02840-9"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.09.003"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190832"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4171-4"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx225"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13390"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000996"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2022.0741"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3461"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-27960-2"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00318"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05704-0"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-024-01554-y"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.5570"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5012"}],"container-title":["Canadian Association of Radiologists Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08465371251334929","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08465371251334929","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08465371251334929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:55:20Z","timestamp":1777384520000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08465371251334929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/08465371251334929"],"URL":"https:\/\/doi.org\/10.1177\/08465371251334929","relation":{},"ISSN":["0846-5371","1488-2361"],"issn-type":[{"value":"0846-5371","type":"print"},{"value":"1488-2361","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}